It is a trading public limited company based in Ernakulam, Kerala, India, established in 1998.
1998 | Ernakulam, Kerala, India | ActiveChemwel Pharma Limited, a active public limited company, was established on 26 February 1998 in Ernakulam, Kerala, India. Engaging in wholesale within the trade sector, it holds CIN: U24231KL1998PLC012114. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹3.21 M.
It upholds a compliant status. Its leadership includes Joshy John (Managing Director), Sreekanth Raveendran (Director), Soney Swamini Raveendran (Director). Past directors included Ranjith Kandamuthan, Jaison Varghese, Joshy John. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at 46/1050-A(1), Ushus Building, Near Lic Office, Chittor Road, Vaduthala P.O.,, Ernakulam, Kerala, 682023.
U24231KL1998PLC012114
012114
26 February 1998
₹1.00 Cr
₹3.21 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Chemwel Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Joshy John | Managing Director | 22 Nov 2013 | Current |
| Sreekanth Raveendran | Director | 22 Nov 2013 | Current |
| Soney Swamini Raveendran | Director | 23 Jul 2016 | Current |
| Ratheesh Menon Pushpavenibalakrishna | Additional Director | 23 Nov 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Jun 2020 | Past |
| Pramod Abcsdd | Director | 21 Nov 2024 | Past |
| Pramod Abcsdd | Director | 20 Jan 2014 | Past |
| Pramod Abcsdd | Director | 26 Jun 2016 | Past |
| Pramod Abcsdd | Additional Director | 12 Apr 2018 | Past |
| Pramod Abcsdd | Director | 22 Nov 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Chemwel Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.49% increase. The company also saw a substantial improvement in profitability, with a 10.84% increase in profit. The company's net worth moved up by a moderate rise of 4.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Chemwel Pharma had a promoter holding of 72.18% and a public holding of 27.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Chemwel Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Chemwel Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemwel Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Chemwel Pharma Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Chemwel Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
Ratheesh Menon Pushpavenibalakrishna was appointed as a Additional Director was appointed as a Additional Director on 23 Nov 2019 & has been associated with this company since 6 years 10 days . was recorded as a recent event.
Soney Swamini Raveendran was appointed as a Director was appointed as a Director on 23 Jul 2016 & has been associated with this company since 9 years 4 months . was recorded as a recent event.
The activity Joshy John was appointed as a Managing Director was appointed as a Managing Director on 22 Nov 2013 & has been associated with this company since 12 years 10 days . was completed.
The activity Sreekanth Raveendran was appointed as a Director was appointed as a Director on 22 Nov 2013 & has been associated with this company since 12 years 10 days . was completed.
The CIN of Chemwel Pharma Limited is U24231KL1998PLC012114.
Chemwel Pharma Limited is headquartered at 46/1050-A(1), Ushus Building, Near Lic Office, Chittor Road, Vaduthala P.O.,, Ernakulam, Kerala, 682023.
Chemwel Pharma Limited was incorporated on 26 February 1998.
The current directors of Chemwel Pharma Limited are
The primary industry of Chemwel Pharma Limited is Trade.
Chemwel Pharma Limited is unlisted.
The authorized capital of Chemwel Pharma Limited is ₹1.00 Cr, and the paid-up capital is ₹3.21 M.
The compliance status of Chemwel Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX